Shengwen Liang

Title: Innovations of Shengwen Liang

Introduction

Shengwen Liang is a notable inventor based in Athens, OH (US). He has made significant contributions to the field of biotechnology, holding a total of 2 patents. His work focuses on developing advanced systems that enhance the capabilities of immunocytes.

Latest Patents

Liang's latest patents include a "Programmable Immunocyte Receptor Complex System." This innovative system features a programmable receptor complex expressed by an immunocyte, which includes a variety of engineered receptor subunits. These subunits are designed to bind to target detector molecules, facilitating interactions with predetermined targets.

Another significant patent is for "Fluorescent Fusion Proteins for Use as Reporters in Multiplexed Bioassays." This bioassay is designed for the detection of multiple target analytes and incorporates living immunocytes. Each immunocyte contains a signal-generating reporter that responds to changes within the cell, ultimately generating a detectable signal when specific analytes are bound.

Career Highlights

Shengwen Liang is currently employed at Fundamental Solutions Corporation, where he continues to innovate and develop new technologies. His work has positioned him as a key figure in the biotechnology sector, contributing to advancements that have the potential to impact various applications in health and medicine.

Collaborations

Liang collaborates with several talented individuals, including Joel S. Lwande and Joseph D. Kittle. These partnerships enhance the research and development efforts at Fundamental Solutions Corporation.

Conclusion

Shengwen Liang's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His innovative approaches to immunocyte technology are paving the way for future advancements in the field.